Today: 30 June 2026
Carvana closes lower into year-end as Fed minutes loom and trading thins
29 December 2025
2 mins read

Carvana closes lower into year-end as Fed minutes loom and trading thins

NEW YORK, December 28, 2025, 11:10 PM ET — Market closed

  • Carvana shares fell 0.7% on Friday, closing at $438.47.
  • U.S. stocks ended little changed near record highs in holiday-thinned trading.
  • Investors head into the final sessions of 2025 with Fed meeting minutes and rate-cut expectations in focus.

Carvana Co. shares ended down 0.7% at $438.47 on Friday as U.S. markets drifted in a quiet post-Christmas session.

The stock has drawn fresh attention this month after Carvana joined the S&P 500, a shift that can pull in buying from funds that track the benchmark.

That matters heading into the final trading days of 2025, when thinner volumes can magnify swings and investors are looking for clues on the path for interest rates in 2026.

On Friday, the S&P 500 slipped 0.03% to 6,929.94, while the Dow fell 0.04% and the Nasdaq lost 0.09%, leaving the major indexes near record peaks.

Carvana traded between $436.74 and $446.39 in the session.

Moves across auto retailers were mixed, with CarMax up 0.2%, AutoNation down 0.3% and Lithia Motors down 0.6%.

No immediate company-specific catalyst was evident for the day’s slip, as broader markets lacked fresh drivers during the holiday lull.

S&P Dow Jones Indices said earlier this month that Carvana would be added to the S&P 500 effective prior to the open on Dec. 22 as part of its quarterly rebalance, a periodic reshuffling of index membership.

Reuters reported the inclusion capped a turnaround for the online used-car seller, known for its “car vending machine” marketing, after the company had faced deep investor skepticism in 2022. Reuters

The company last reported quarterly results in October, when it posted higher third-quarter profit and revenue as demand for used vehicles held up, Reuters reported.

Broader risk appetite has also held up late in the year as investors bet the economy can withstand a gradual easing cycle. “There are more investors that are buying in to the narrative that the economy is on pretty solid footing right now,” Anthony Saglimbene, chief market strategist at Ameriprise Financial, said. Reuters

The Federal Reserve has cut rates by 75 basis points over its last three meetings of 2025 to a target range of 3.50% to 3.75%, Reuters reported. The minutes from its Dec. 9-10 meeting are due on Tuesday, Dec. 30.

Before next session, investors will watch whether thin year-end trading exaggerates moves in high-beta consumer discretionary stocks such as Carvana, even on modest headlines.

The Fed minutes are the next scheduled market catalyst, while traders also remain alert for any signals on President Donald Trump’s choice for the next Fed chair, with Jerome Powell’s term set to end in May.

Technically, the stock’s Friday range of $436.74 to $446.39 sets near-term reference points as the last sessions of the year get underway.

Carvana has not posted its next “upcoming event” on its investor relations site, leaving investors to focus on macro conditions that shape car affordability — particularly interest rates — until the company provides its next scheduled update. Carvana Investors+1

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Rare €2 Coins to Check in 2025: The Truth About the 2002 Greek “S in the Star” and What’s Actually Worth Money
Previous Story

Rare €2 Coins to Check in 2025: The Truth About the 2002 Greek “S in the Star” and What’s Actually Worth Money

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Next Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Go toTop